- Home
- Publications
- Publication Search
- Publication Details
Title
Breast cancer vaccines for treatment and prevention
Authors
Keywords
-
Journal
BREAST CANCER RESEARCH AND TREATMENT
Volume 191, Issue 3, Pages 481-489
Publisher
Springer Science and Business Media LLC
Online
2021-12-01
DOI
10.1007/s10549-021-06459-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Vaccines: Adjuvant Potency, Importance of Age, Lifestyle, and Treatments
- (2021) Stefania Cuzzubbo et al. Frontiers in Immunology
- Improving the Odds in Advanced Breast Cancer With Combination Immunotherapy: Stepwise Addition of Vaccine, Immune Checkpoint Inhibitor, Chemotherapy, and HDAC Inhibitor in Advanced Stage Breast Cancer
- (2021) Margaret E. Gatti-Mays et al. Frontiers in Oncology
- Novel approaches for vaccine development
- (2021) Makda S. Gebre et al. CELL
- Type I T cells sensitize treatment refractory tumors to chemotherapy through inhibition of oncogenic signaling pathways
- (2021) Denise Cecil et al. Journal for ImmunoTherapy of Cancer
- Tissue-resident memory T cells in breast cancer control and immunotherapy responses
- (2020) Ann Byrne et al. Nature Reviews Clinical Oncology
- Tumor-associated O-glycans of MUC1: Carriers of the glyco-code and targets for cancer vaccine design
- (2020) Donella M. Beckwith et al. SEMINARS IN IMMUNOLOGY
- High tumor mutation burden is associated with DNA damage repair gene mutation in breast carcinomas
- (2020) Ping Mei et al. Diagnostic Pathology
- MHC-restricted phosphopeptide antigens: preclinical validation and first-in-humans clinical trial in participants with high-risk melanoma
- (2020) Victor H Engelhard et al. Journal for ImmunoTherapy of Cancer
- Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34)
- (2020) Christian F. Singer et al. EUROPEAN JOURNAL OF CANCER
- Globo H-KLH vaccine adagloxad simolenin (OBI-822)/OBI-821 in patients with metastatic breast cancer: phase II randomized, placebo-controlled study
- (2020) Chiun-Sheng Huang et al. Journal for ImmunoTherapy of Cancer
- Vaccines as remedy for antimicrobial resistance and emerging infections
- (2020) Marco Troisi et al. CURRENT OPINION IN IMMUNOLOGY
- New horizons in adjuvants for vaccine development
- (2020) Steven G Reed et al. CURRENT OPINION IN IMMUNOLOGY
- Advances in Lipid Nanoparticles for mRNA-Based Cancer Immunotherapy
- (2020) Maria L. Guevara et al. Frontiers in Chemistry
- Semi-supervised learning for somatic variant calling and peptide identification in personalized cancer immunotherapy
- (2020) Elham Sherafat et al. BMC BIOINFORMATICS
- First‐in‐human study of the cancer peptide vaccine, TAS0313, in patients with advanced solid tumors
- (2020) Shunsuke Kondo et al. CANCER SCIENCE
- Efficacy of cancer vaccines in selected gynaecological breast and ovarian cancers: A 20-year systematic review and meta-analysis
- (2020) U. Dafni et al. EUROPEAN JOURNAL OF CANCER
- Personal Neoantigen Cancer Vaccines: A Road Not Fully Paved
- (2020) Edward F. Fritsch et al. Cancer Immunology Research
- Citrullination in Cancer
- (2019) Arseniy E. Yuzhalin CANCER RESEARCH
- Recent advances in carbohydrate-based cancer vaccines
- (2019) Ke-Tao Jin et al. BIOTECHNOLOGY LETTERS
- The clinical and biological significance of HER2 over-expression in breast ductal carcinoma in situ: a large study from a single institution
- (2019) Islam M. Miligy et al. BRITISH JOURNAL OF CANCER
- Efficacy and Safety Analysis of Nelipepimut-S Vaccine to Prevent Breast Cancer Recurrence: A Randomized, Multicenter, Phase III Clinical Trial
- (2019) Elizabeth A. Mittendorf et al. CLINICAL CANCER RESEARCH
- Cancer DNA vaccines: current preclinical and clinical developments and future perspectives
- (2019) Alessandra Lopes et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Current Landscape of Immunotherapy in Breast Cancer
- (2019) Sylvia Adams et al. JAMA Oncology
- Immunogenicity of Tumor Initiating Stem Cells: Potential Applications in Novel Anticancer Therapy
- (2019) Durga Khandekar et al. Frontiers in Oncology
- Endogenous antibody responses to mucin 1 in a large multiethnic cohort of patients with breast cancer and healthy controls: Role of immunoglobulin and Fcγ receptor genes
- (2018) Janardan P. Pandey et al. IMMUNOBIOLOGY
- Immune recognition of somatic mutations leading to complete durable regression in metastatic breast cancer
- (2018) Nikolaos Zacharakis et al. NATURE MEDICINE
- Nanoliposomes carrying HER2/neu-derived peptide AE36 with CpG-ODN exhibit therapeutic and prophylactic activities in a mice TUBO model of breast cancer
- (2017) Nastaran Barati et al. IMMUNOLOGY LETTERS
- Protective effect of naturally occurring anti-HER2 autoantibodies on breast cancer
- (2016) Yukiko Tabuchi et al. BREAST CANCER RESEARCH AND TREATMENT
- Immunization against HIF-1α Inhibits the Growth of Basal Mammary Tumors and Targets Mammary Stem CellsIn Vivo
- (2016) Denise L. Cecil et al. CLINICAL CANCER RESEARCH
- CD4+ T-cell help amplifies innate signals for primary CD8+ T-cell immunity
- (2016) Sammy Bedoui et al. IMMUNOLOGICAL REVIEWS
- Selection of epitopes from self-antigens for eliciting Th2 or Th1 activity in the treatment of autoimmune disease or cancer
- (2016) William C. Watt et al. Seminars in Immunopathology
- Immunological Characterization of Whole Tumour Lysate-Loaded Dendritic Cells for Cancer Immunotherapy
- (2016) Veronica Rainone et al. PLoS One
- The Antigenic Repertoire of Premalignant and High-Risk Lesions
- (2015) J. P. Marquez et al. Cancer Prevention Research
- An Autoimmune Response Signature Associated with the Development of Triple-Negative Breast Cancer Reflects Disease Pathogenesis
- (2015) H. Katayama et al. CANCER RESEARCH
- Therapeutic efficacy of PD-L1 blockade in a breast cancer model is enhanced by cellular vaccines expressing B7-1 and glycolipid-anchored IL-12
- (2015) Erica N Bozeman et al. Human Vaccines & Immunotherapeutics
- Mucin 1-specific B cell immune responses and their impact on overall survival in breast cancer patients
- (2015) Carlo Fremd et al. OncoImmunology
- Elimination of IL-10-Inducing T-Helper Epitopes from an IGFBP-2 Vaccine Ensures Potent Antitumor Activity
- (2014) D. L. Cecil et al. CANCER RESEARCH
- Is the "3+3" Dose-Escalation Phase I Clinical Trial Design Suitable for Therapeutic Cancer Vaccine Development? A Recommendation for Alternative Design
- (2014) O. E. Rahma et al. CLINICAL CANCER RESEARCH
- The immune contexture of primary and metastatic human tumours
- (2014) Nicolas A Giraldo et al. CURRENT OPINION IN IMMUNOLOGY
- Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer
- (2014) Jianning Mao et al. Journal of Translational Medicine
- T-helper I immunity, specific for the breast cancer antigen insulin-like growth factor-I receptor (IGF-IR), is associated with increased adiposity
- (2013) Denise L. Cecil et al. BREAST CANCER RESEARCH AND TREATMENT
- Identification of Putative Immunologic Targets for Colon Cancer Prevention Based on Conserved Gene Upregulation from Preinvasive to Malignant Lesions
- (2013) E. K. Broussard et al. Cancer Prevention Research
- A Multiantigen Vaccine Targeting Neu, IGFBP-2, and IGF-IR Prevents Tumor Progression in Mice with Preinvasive Breast Disease
- (2013) M. L. Disis et al. Cancer Prevention Research
- Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant
- (2013) Abbi L. Engel et al. IMMUNOBIOLOGY
- HER-2 pulsed dendritic cell vaccine can eliminate HER-2 expression and impact ductal carcinoma in situ
- (2012) Anupama Sharma et al. CANCER
- Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
- (2012) D. T. Le et al. CANCER RESEARCH
- Dendritic Cell-Activating Vaccine Adjuvants Differ in the Ability to Elicit Antitumor Immunity Due to an Adjuvant-Specific Induction of Immunosuppressive Cells
- (2012) Y. Dang et al. CLINICAL CANCER RESEARCH
- A Cancer Vaccine Induces Expansion of NY-ESO-1-Specific Regulatory T Cells in Patients with Advanced Melanoma
- (2012) Lisa M. Ebert et al. PLoS One
- Phase III Multicenter Clinical Trial of the Sialyl-TN (STn)-Keyhole Limpet Hemocyanin (KLH) Vaccine for Metastatic Breast Cancer
- (2011) D. Miles et al. ONCOLOGIST
- Polysaccharide Krestin Is a Novel TLR2 Agonist that Mediates Inhibition of Tumor Growth via Stimulation of CD8 T Cells and NK Cells
- (2010) H. Lu et al. CLINICAL CANCER RESEARCH
- Immune Regulation of Cancer
- (2010) Mary L. Disis JOURNAL OF CLINICAL ONCOLOGY
- Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
- (2010) Philip W. Kantoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Impact of HER2/neu Expression Level on Response to the E75 Vaccine: From U.S. Military Cancer Institute Clinical Trials Group Study I-01 and I-02
- (2009) L. C. Benavides et al. CLINICAL CANCER RESEARCH
- Insulin-like Growth Factor-Binding Protein-2 Is a Target for the Immunomodulation of Breast Cancer
- (2008) K. H. Park et al. CANCER RESEARCH
- Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity
- (2008) V. Goodell et al. MOLECULAR CANCER THERAPEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation